Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

NCT00110396 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: Interferon-beta-1a FBS-free/HSA-free

Sponsor

EMD Serono

Collaborators

[object Object]